放疗、影像技术与化疗发展与非转移性鼻咽癌生存改善的队列研究(1990-2012)
该研究分析1990至2012年间20305例接受放疗的非转移性鼻咽癌患者,按4个日历时期分组,主要终点为总生存。结果显示各TNM分期的5年总生存逐期提高,无进展生存和局部区域无复发生存呈相似趋势,远处无转移生存差异较小。多因素分析显示调强放疗和磁共振成像的应用是独立保护因素,化疗使总生存、无进展生存和局部区域无复发生存获益,治疗失败模式由复发转向远处转移。
要点
- 各TNM分期的5年总生存随4个日历时期逐期提高,局部区域控制良好。
- 调强放疗和磁共振成像的应用是总生存、无进展生存、局部区域无复发生存和远处无转移生存的独立保护因素。
- 化疗使总生存、无进展生存和局部区域无复发生存获益,治疗失败模式由复发转向远处转移。
核心结论
- 放疗、影像技术和化疗的发展通过良好的局部区域控制提高了鼻咽癌患者的生存率。
- 远处失败已成为鼻咽癌治疗的最大挑战。
研究设计与样本
- 回顾性队列研究,分析1990至2012年间20305例接受放疗的非转移性鼻咽癌患者。
- 患者按4个日历时期分组:1990-1996、1997-2002、2003-2007和2008-2012,主要终点为总生存。
主要发现
- 自2003年起磁共振成像取代计算机断层扫描成为最重要的影像技术。
- 2008年前二维常规放疗为主要技术,此后被调强放疗取代。
- 自2003年起接受化疗的患者逐渐增多。
- 4个日历时期的5年总生存在各TNM分期均逐期提高,无进展生存和局部区域无复发生存呈相似趋势,远处无转移生存差异较小。
- 多因素分析显示调强放疗和磁共振成像的应用是总生存、无进展生存、局部区域无复发生存和远处无转移生存的独立保护因素,化疗使总生存、无进展生存和局部区域无复发生存获益。
关键数值与推荐
- 主要治疗失败模式由复发转向远处转移。
临床怎么用
- 非转移性鼻咽癌放疗应推广调强放疗和磁共振成像的应用以改善生存。
- 化疗可使非转移性鼻咽癌患者在总生存、无进展生存和局部区域无复发生存方面获益。
- 远处转移已成为主要失败模式,需加强远处转移的防控策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Previous studies demonstrated that the radiation therapy, image technology, and the application of chemotherapy have developed in the last 2 decades. This study explored the survival trends and treatment failure patterns of patients with nonmetastatic nasopharyngeal carcinoma (NPC) treated with radiation therapy. Furthermore, we evaluated the survival benefit brought by the development of radiation therapy, image technology, and chemotherapy based on a large cohort from 1990 to 2012. METHODS AND MATERIALS: Data from 20,305 patients with nonmetastatic NPC treated between 1990 and 2012 were analyzed. Patients were divided into 4 calendar periods (1990-1996, 1997-2002, 2003-2007, and 2008-2012). Overall survival (OS) was the primary endpoint. RESULTS: Magnetic resonance imaging has replaced computed tomography as the most important imaging technique since 2003. Conventional 2-dimensional radiation therapy, which was the main radiation therapy technique in our institution before 2008, was replaced by intensity modulated radiation therapy later. An increasing number of patients have undergone chemotherapy since 2003. The 5-year OS across the 4 calendar periods increased at each TNM stage with progression-free survival (PFS) and locoregional relapse-free survival (LRFS) showing a similar trend, whereas distant metastasis-free survival showed small differences. Multivariate analyses showed that the application of intensity modulated radiation therapy and magnetic resonance imaging were independent protective factors in OS, PFS, LRFS, and distant metastasis-free survival. Chemotherapy benefited patients in OS, PFS, and LRFS. The main pattern of treatment failure shifted from recurrence to distant metastasis. CONCLUSIONS: The development of radiation therapy, image technology, and chemotherapy increased survival rates among patients with NPC because of excellent locoregional control. Distant failure has become the greatest challenge for NPC treatment.
引用
- Sun XS, Liu SL, Luo MJ, et al. The Association Between the Development of Radiation Therapy, Image Technology, and Chemotherapy, and the Survival of Patients With Nasopharyngeal Carcinoma: A Cohort Study From 1990 to 2012. Int J Radiat Oncol Biol Phys. 2019. PMID: 31319091. doi:10.1016/j.ijrobp.2019.06.2549
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。